OFTAOX
hyaluronate de sodium
Active substance
hyaluronate de sodium
Laboratory
NON RENSEIGNÉ
What is this medicine?
OFTAOX contains hyaluronate de sodium. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
hyaluronate de sodium, Solution ophtalmique, 0.25, Flacon de 8 ml
Common uses
Use is linked to the active substance, the selected indication, and the pharmaceutical form.
Class
Générique
Laboratory
NON RENSEIGNÉ
Strength
0.25
Form
Solution ophtalmique
Presentation
Flacon de 8 ml
Type
Générique
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: Not available in the verified source
Medicines with the same active substance
NEOPT MULTI 0.2 %
0.2 % · Flacon de 15 ml multidoses
84,00 MAD
ARTROVIAL
2.2 % · Boite d'une seringue stérile à 2.2 % pré-remplie de 2 ml pour injection intra-articulaire
295,00 MAD
ARTROVIAL
Seringue pour injection intra-articulaire
295,00 MAD
HYALGAN 20 MG / 2 ML
20 MG / 2 ML · 1 seringues de 2 ml
316,00 MAD
ARTROVIAL
2.2 % · Boite de 3 seringues stériles à 2.2% pré-remplie de 2 ml pour injection intra-articulaire
840,00 MAD
ARTROVIAL
2 ml · Boite de 3 seringues stériles à 2.2% pré-remplie de 2 ml pour injection intra-articulaire
840,00 MAD
ELVIA
0.15 · Flacon de 15 ml
Not available in the verified source
ELVIA PLUS
0.4 ml · Flacon de 10 ml
Not available in the verified source
HYALONE 60 MG / 4 ML
60 MG / 4 ML · Boite unitaire
Not available in the verified source
HYE
Solution ophtalmique · Flacon de 10 ML
Not available in the verified source